AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31720788 — intervention group
Group type: COMPARATOR
Intervention: Standard ablation techniques
Number of subjects: 0
Study 29518425 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (20 mg twice daily)
Number of subjects: 16
Study 29518425 — intervention group
Group type: COMPARATOR
Intervention: LTE4 inhalation
Number of subjects: 16
Study 26574567 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling regarding lifestyle behaviors (diet, weight loss, exercise)
Number of subjects: 388
Study 24281911 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.4% carbohydrate/electrolyte sports drink ingested 30 minutes before exercise (C30)
Number of subjects: 27
Study 24281911 — intervention group
Group type: COMPARATOR
Intervention: Flavor-matched placebo administered 30 minutes before exercise (P30)
Number of subjects: 27
Study 24281911 — intervention group
Group type: COMPARATOR
Intervention: Flavor-matched placebo administered 120 minutes before exercise (P120)
Number of subjects: 27
Study 24281911 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.4% carbohydrate/electrolyte sports drink ingested 120 minutes before exercise (C120)
Number of subjects: 27
Study 24281911 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% carbohydrate solution ingested 30 minutes before exercise
Number of subjects: 27
Study 24281911 — intervention group
Group type: EXPERIMENTAL
Intervention: 0% carbohydrate solution ingested 30 minutes before exercise
Number of subjects: 27
Study 24281911 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% carbohydrate solution ingested 30 minutes before exercise
Number of subjects: 27
Study 22990680 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured transfer group (written and verbal sign-outs)
Number of subjects: 32
Study 21114950 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram treatment
Number of subjects: 2280
Study 21114950 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom change from baseline to week 2
Number of subjects: 2280
Study 21114950 — intervention group
Group type: EXPERIMENTAL
Intervention: Recursive subsetting algorithm using baseline features and symptom change
Number of subjects: 2280
Study 18768007 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week community-based relapse prevention (RP) programme
Number of subjects: 20
Study 18768007 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 20
Study 15839797 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg cortisol
Number of subjects: 59
Study 15839797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 12887481 — intervention group
Group type: EXPERIMENTAL
Intervention: 320 mg S. repens extract
Number of subjects: 100
Study 12887481 — intervention group
Group type: COMPARATOR
Intervention: Placebo (paraffin oil)
Number of subjects: 100
Study 10485422 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-bonded (Carmeda) circuits
Number of subjects: 210
Study 10485422 — intervention group
Group type: COMPARATOR
Intervention: Non-bonded circuits
Number of subjects: 210
Study 7815572 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric kidneys
Number of subjects: 183
Study 7815572 — intervention group
Group type: COMPARATOR
Intervention: Adult kidneys
Number of subjects: 183
Study 7815572 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 183
Study 1938849 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 40 mg
Number of subjects: 0
Study 1938849 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 80 mg
Number of subjects: 0
Study 1938849 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 0
Study 1938849 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 15 mg
Number of subjects: 0
Study 1938849 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1938849 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 5 mg
Number of subjects: 0
Study 7007061 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 0
Study 7007061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31923193 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol (50 ?g every four hours as needed)
Number of subjects: 511
Study 31923193 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose vaginal misoprostol (25 to 50 ?g every six hours as needed)
Number of subjects: 511
Study 31923193 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal dinoprostone (one to two mg every six hours as needed)
Number of subjects: 511
Study 31923193 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 511
Study 31923193 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose vaginal misoprostol
Number of subjects: 511
Study 31923193 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal dinoprostone
Number of subjects: 511
Study 31085679 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide (NAM) 750 mg twice daily plus Lanthanum Carbonate (LC) 1000 mg thrice daily
Number of subjects: 205
Study 31085679 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide (NAM) plus LC placebo
Number of subjects: 205
Study 31085679 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum Carbonate (LC) plus NAM placebo
Number of subjects: 205
Study 31085679 — intervention group
Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 205
Study 29281192 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried salted plum consumption during HBO₂ therapy
Number of subjects: 90
Study 29281192 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dried salted plum)
Number of subjects: 90
Study 26350942 — intervention group
Group type: COMPARATOR
Intervention: Alternating arm motion no WBV (Alt_NoWBV)
Number of subjects: 28
Study 26350942 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating arm motion 30 Hz low amplitude WBV (Alt_30 Hz-L)
Number of subjects: 28
Study 26350942 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating arm motion 50 Hz high amplitude WBV (Alt_50 Hz-H)
Number of subjects: 28
Study 26350942 — intervention group
Group type: COMPARATOR
Intervention: Double arm motion no WBV (Double_NoWBV)
Number of subjects: 28
Study 26350942 — intervention group
Group type: EXPERIMENTAL
Intervention: Double arm motion 30Hz low amplitude WBV (Double_30Hz-L)
Number of subjects: 28
Study 26350942 — intervention group
Group type: EXPERIMENTAL
Intervention: Double arm motion 50 Hz high amplitude WBV (Double_50 Hz-H)
Number of subjects: 28
Study 25398689 — intervention group
Group type: EXPERIMENTAL
Intervention: Abediterol 0.313 μg
Number of subjects: 62
Study 25398689 — intervention group
Group type: EXPERIMENTAL
Intervention: Abediterol 0.625 μg
Number of subjects: 62
Study 25398689 — intervention group
Group type: EXPERIMENTAL
Intervention: Abediterol 1.25 μg
Number of subjects: 62
Study 25398689 — intervention group
Group type: EXPERIMENTAL
Intervention: Abediterol 2.5 μg
Number of subjects: 62
Study 25398689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 25398689 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of Abediterol
Number of subjects: 62
Study 22260858 — intervention group
Group type: EXPERIMENTAL
Intervention: Doenjang (9.9 g/d for 12 weeks)
Number of subjects: 51
Study 22260858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 19685958 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 0
Study 19685958 — intervention group
Group type: COMPARATOR
Intervention: Placebo consumption
Number of subjects: 0
Study 19685958 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption (post-intoxication)
Number of subjects: 0
Study 17927645 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-administered behavioral migraine management program (TAT)
Number of subjects: 34
Study 17927645 — intervention group
Group type: COMPARATOR
Intervention: Standard Triptan Treatment (TT)
Number of subjects: 34
Study 15375787 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/d Wheat germ policosanol (WGP) for 4 weeks
Number of subjects: 58
Study 15375787 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control) for 4 weeks
Number of subjects: 58
Study 15375787 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat germ policosanol (WGP)
Number of subjects: 58
Study 11493041 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted preventive nutrition intervention (mailed dietary recommendations, verbal endorsement by primary care provider, two motivational counseling sessions)
Number of subjects: 504
Study 11493041 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 504
Study 11493041 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted preventive nutrition intervention
Number of subjects: 504
Study 9733054 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-2, 9000000 IU subcutaneously twice daily for 3 days before surgery
Number of subjects: 40
Study 9733054 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rhIL-2 administration)
Number of subjects: 40
Study 9733054 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-2 group
Number of subjects: 40
Study 9733054 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 7984740 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home therapy program (6 weeks)
Number of subjects: 76
Study 7984740 — intervention group
Group type: COMPARATOR
Intervention: Traditional county services (no in-home therapy)
Number of subjects: 76
Study 2725163 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment (antimicrobial chemotherapeutic agents)
Number of subjects: 119
Study 2725163 — intervention group
Group type: COMPARATOR
Intervention: Ototopical treatment (nonallergenic disinfectants)
Number of subjects: 119
Study 2725163 — intervention group
Group type: EXPERIMENTAL
Intervention: Azactam (systemic treatment)
Number of subjects: 119
Study 2725163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole plus trimethoprim (systemic treatment)
Number of subjects: 119
Study 2725163 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (systemic treatment)
Number of subjects: 119
Study 2725163 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin plus metronidazole (systemic treatment)
Number of subjects: 119
Study 786170 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% tretinoin followed by a potent corticosteroid ointment
Number of subjects: 0
Study 786170 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid ointment alone
Number of subjects: 0
Study 786170 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin alone
Number of subjects: 0
Study 31953834 — intervention group
Group type: EXPERIMENTAL
Intervention: Turkish art music
Number of subjects: 150
Study 31953834 — intervention group
Group type: EXPERIMENTAL
Intervention: Western classical music
Number of subjects: 150
Study 31953834 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient's preferred music type
Number of subjects: 150
Study 31953834 — intervention group
Group type: COMPARATOR
Intervention: No music (Group 2)
Number of subjects: 150
Study 31953834 — intervention group
Group type: COMPARATOR
Intervention: No music (Group 1)
Number of subjects: 150
Study 31075722 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandospirone + escitalopram
Number of subjects: 100
Study 31075722 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 100
Study 27702846 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (10-40 mg daily)
Number of subjects: 106
Study 27702846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 25300198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoanalgesia (intercostal nerve cryoanalgesia)
Number of subjects: 178
Study 25300198 — intervention group
Group type: COMPARATOR
Intervention: Parecoxib
Number of subjects: 178
Study 22669936 — intervention group
Group type: EXPERIMENTAL
Intervention: Family therapy in the context of palliative care
Number of subjects: 17
Study 22041483 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol eye drops administered topically twice per day from the second week through the end of the first month.
Number of subjects: 60
Study 22041483 — intervention group
Group type: COMPARATOR
Intervention: Control group (no timolol treatment).
Number of subjects: 60
Study 18845976 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) with passive stretching (frequency = 26 Hz) for five 1-min bouts
Number of subjects: 20
Study 18845976 — intervention group
Group type: COMPARATOR
Intervention: Nonvibration treatment with passive stretching for five 1-min bouts
Number of subjects: 20
Study 16398892 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-SET
Number of subjects: 28
Study 16398892 — intervention group
Group type: COMPARATOR
Intervention: 1-SET
Number of subjects: 28
Study 16398892 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-SET and 3-SET
Number of subjects: 28
Study 14660727 — intervention group
Group type: EXPERIMENTAL
Intervention: (90)Y-DOTA-epratuzumab at 0.370 GBq/m(2) for group 1 and 0.185 GBq/m(2) for group 2
Number of subjects: 165
Study 14660727 — intervention group
Group type: EXPERIMENTAL
Intervention: (90)Y-DOTA-epratuzumab
Number of subjects: 165
Study 14660727 — intervention group
Group type: EXPERIMENTAL
Intervention: (111)In-DOTA-epratuzumab
Number of subjects: 165
Study 10651782 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine 4 mg (oral) once daily for 7 days
Number of subjects: 8
Study 10651782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 12013487 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg once daily in the morning for 4 weeks
Number of subjects: 590
Study 1538580 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine (3 g/day)
Number of subjects: 17
Study 1538580 — intervention group
Group type: COMPARATOR
Intervention: Coenzyme Q10 (30 mg/day)
Number of subjects: 17
Study 6380724 — intervention group
Group type: EXPERIMENTAL
Intervention: Lormetazepam 1 mg
Number of subjects: 60
Study 6380724 — intervention group
Group type: EXPERIMENTAL
Intervention: Lormetazepam 2 mg
Number of subjects: 60
Study 6380724 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 60
Study 6380724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30554276 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical activity intervention using Polar A360® activity trackers
Number of subjects: 22
Study 30554276 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical activity intervention
Number of subjects: 22
Study 29351965 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 212
Study 29469258 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group (women with poor pregnant outcomes)
Number of subjects: 217
Study 29469258 — intervention group
Group type: COMPARATOR
Intervention: Control group (women with normal pregnancy)
Number of subjects: 217
Study 24227120 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration plus hypocaloric diet (WBV group)
Number of subjects: 34
Study 24227120 — intervention group
Group type: COMPARATOR
Intervention: Diet alone (CON group)
Number of subjects: 34
Study 22804943 — intervention group
Group type: COMPARATOR
Intervention: Traditional multimodality therapy (gastrolavage, catharsis, methylthioninium chloride, vitamin C, symptomatic treatment)
Number of subjects: 72
Study 22804943 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional multimodality therapy plus scopolamine
Number of subjects: 72
Study 19789153 — intervention group
Group type: EXPERIMENTAL
Intervention: Colesevelam hydrochloride, 3.75 g daily
Number of subjects: 169
Study 19789153 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone maleate, 4 mg daily
Number of subjects: 169
Study 19789153 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin phosphate, 100 mg daily
Number of subjects: 169
Study 17983363 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 degrees raised head of bed (treatment group)
Number of subjects: 30
Study 17983363 — intervention group
Group type: COMPARATOR
Intervention: 25 degrees raised head of bed (control group)
Number of subjects: 30
Study 12946091 — intervention group
Group type: EXPERIMENTAL
Intervention: evidence-based consumer guide to treatments for depression
Number of subjects: 1094
Study 12946091 — intervention group
Group type: COMPARATOR
Intervention: general brochure on depression
Number of subjects: 1094
Study 10881816 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.6 mg/kg
Number of subjects: 235
Study 10881816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study 9197291 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow sevoflurane anesthesia (1 l/min)
Number of subjects: 48
Study 9197291 — intervention group
Group type: COMPARATOR
Intervention: High-flow sevoflurane anesthesia (6-10 l/min)
Number of subjects: 48
Study 9197291 — intervention group
Group type: COMPARATOR
Intervention: Low-flow isoflurane anesthesia (1 l/min)
Number of subjects: 48
Study 7951525 — intervention group
Group type: EXPERIMENTAL
Intervention: MCI‐028 (synthetic human corticotropin-releasing hormone) at doses of 33, 100, and 200 micrograms
Number of subjects: 8
Study 7951525 — intervention group
Group type: EXPERIMENTAL
Intervention: MCI‐028 (synthetic human corticotropin-releasing hormone)
Number of subjects: 8
Study 3082506 — intervention group
Group type: EXPERIMENTAL
Intervention: Monochemotherapy (thiotepa, six courses, 200 mg each course)
Number of subjects: 1228
Study 3082506 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychotherapy (thiotepa, methotrexate, 5‐fluorouracil [TMF], cyclophosphamide, methotrexate, 5‐fluorouracil [CMF], six courses)
Number of subjects: 1228
Study 3082506 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant polychemotherapy (TMF, CMF schemes)
Number of subjects: 1228
Study 3082506 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant mono- and polychemotherapy
Number of subjects: 1228
Study 3082506 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 1228
Study 30085948 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-minute 3D CAIPIRINHA SPACE TSE MRI
Number of subjects: 150
Study 30085948 — intervention group
Group type: COMPARATOR
Intervention: 20-minute standard-of-reference 2D TSE MRI
Number of subjects: 150
Study 27648854 — intervention group
Group type: COMPARATOR
Intervention: Unpaid Training
Number of subjects: 0
Study 27648854 — intervention group
Group type: COMPARATOR
Intervention: Paid Training
Number of subjects: 0
Study 27648854 — intervention group
Group type: COMPARATOR
Intervention: Contingent Paid Training
Number of subjects: 0
Study 27648854 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy drinking days
Number of subjects: 0
Study 27648854 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinks per drinking day
Number of subjects: 0
Study 27648854 — intervention group
Group type: EXPERIMENTAL
Intervention: Days of alcohol abstinence
Number of subjects: 0
Study 24850114 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic alone (Group I)
Number of subjects: 110
Study 24850114 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic with steroids (Group II)
Number of subjects: 110
Study 22414822 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal infiltration with 4% articaine with epinephrine
Number of subjects: 182
Study 22414822 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous injection with 2% lidocaine with epinephrine
Number of subjects: 182
Study 22414822 — intervention group
Group type: COMPARATOR
Intervention: Repeat inferior alveolar nerve block (rIANB) with 2% lidocaine with epinephrine
Number of subjects: 182
Study 22414822 — intervention group
Group type: COMPARATOR
Intervention: Intraligamentary injection (PDL) with 2% lidocaine with epinephrine
Number of subjects: 182
Study 20484066 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (IP)
Number of subjects: 22
Study 20484066 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 20484066 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study 18377382 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral triptans
Number of subjects: 0
Study 18377382 — intervention group
Group type: COMPARATOR
Intervention: Triptans
Number of subjects: 0
Study 18377382 — intervention group
Group type: EXPERIMENTAL
Intervention: Effervescent aspirin
Number of subjects: 0
Study 15946914 — intervention group
Group type: EXPERIMENTAL
Intervention: Microemulsion of cyclosporine, mycophenolatesodium, steroids and basiliximab
Number of subjects: 41
Study 15946914 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased cyclosporine (CsA) dose
Number of subjects: 41
Study 15946914 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased CsA dose after 14 days
Number of subjects: 41
Study 15946914 — intervention group
Group type: EXPERIMENTAL
Intervention: C2 monitoring
Number of subjects: 41
Study 12795353 — intervention group
Group type: EXPERIMENTAL
Intervention: Serrated, parallel‐sided, cast post and core
Number of subjects: 40
Study 12795353 — intervention group
Group type: EXPERIMENTAL
Intervention: Serrated, parallel‐sided, prefabricated post and resin‐composite core
Number of subjects: 40
Study 12795353 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon‐fiber‐reinforced (CFC) post and resin‐composite core
Number of subjects: 40
Study 12795353 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic post and resin‐composite core
Number of subjects: 40
Study 10472212 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute preoperative normovolaemic haemodilution (NHD)
Number of subjects: 0
Study 10472212 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NHD)
Number of subjects: 0
Study 9086872 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracing, drafting, and measurement error for TM joint space analysis (TM-JSA)
Number of subjects: 16
Study 1651894 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurolept anaesthesia
Number of subjects: 26
Study 1651894 — intervention group
Group type: COMPARATOR
Intervention: Enflurane
Number of subjects: 26
Study 1651894 — intervention group
Group type: EXPERIMENTAL
Intervention: Both anaesthesia types
Number of subjects: 26